Development of new methods for the synthesis of biologically active natural products
开发合成具有生物活性的天然产物的新方法
基本信息
- 批准号:326980-2009
- 负责人:
- 金额:$ 3.64万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Grants Program - Individual
- 财政年份:2011
- 资助国家:加拿大
- 起止时间:2011-01-01 至 2012-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
It is difficult to overstate the importance of natural products to human health. The near doubling of the life expectancy for the average Canadian in the 20th century is largely attributed to medical advances based on natural products and over 50% of drugs approved by the FDA in the past 25 years are, or their origins can be traced to, natural products. Recent advances in biochemistry and molecular biology, that includes the development of high-throughput assays for rapidly identifying biologically active compounds, has enabled the discovery of many new natural products with a fascinating range of biological activities and structural diversity. However, due to often-limited amounts of material available from the natural source or environmental concerns associated with harvesting the producing organism, the full realization of these discoveries relies on simultaneous breakthroughs in synthetic chemistry, or total synthesis, necessary to assemble the biologically active compound in the laboratory. Thus, through total synthesis organic chemists provide a renewable source of the natural product, and generate sufficient quantities for unambiguous structural assignment and thorough biological testing. Bearing this in mind, the major focus of our research program is the total synthesis of natural products that represent potential lead candidates for the treatment of human diseases, and insect sex pheromones that provide earth-friendly alternatives to insecticides. These studies rely heavily on the development of innovative reactions that will allow us to construct complex natural products in a straightforward manner from simple chemical building blocks. In particular, we plan to develop reactions that will provide rapid access to haterumalide, a potential anticancer agent; hyacinthacine A5, a potential antidiabetic agent; and chimonanthine, an analgesic natural product. Our flexible syntheses of these molecules will also allow us to generate new substances, similar in structure to these natural products but with potentially improved pharmaceutical properties. The successful implementation of this program will enable discoveries fundamental to our basic understanding of organic chemistry and the development of pharmaceuticals.
天然产品对人类健康的重要性再怎么强调也不为过。20世纪,加拿大人的平均寿命几乎翻了一番,这在很大程度上要归功于基于天然产物的医学进步。在过去的25年里,美国食品和药物管理局批准的50%以上的药物都是天然产物,或者它们的来源可以追溯到天然产物。生物化学和分子生物学的最新进展,包括用于快速识别生物活性化合物的高通量分析的发展,使许多具有迷人生物活性和结构多样性的新天然产物得以发现。然而,由于从自然来源获得的材料数量通常有限,或者与收获生产生物体有关的环境问题,这些发现的充分实现依赖于合成化学或全合成的同时突破,这是在实验室中组装生物活性化合物所必需的。因此,通过全合成,有机化学家提供了天然产物的可再生来源,并为明确的结构分配和彻底的生物测试产生了足够的数量。考虑到这一点,我们研究项目的主要重点是天然产物的全合成,这些天然产物代表了治疗人类疾病的潜在主要候选物,而昆虫性信息素则提供了对地球无害的杀虫剂替代品。这些研究在很大程度上依赖于创新反应的发展,这些反应将使我们能够从简单的化学构建块中以直接的方式构建复杂的天然产物。特别是,我们计划开发能够快速获得haterumalide(一种潜在的抗癌剂)的反应;风信子A5,一种潜在的降糖药;还有chimonanthine,一种镇痛的天然产物。我们对这些分子的灵活合成也将使我们能够产生新的物质,在结构上与这些天然产物相似,但具有潜在的改进的药物性能。这一计划的成功实施将使我们对有机化学的基本理解和药物的发展产生根本性的发现。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Britton, Robert其他文献
Total Synthesis of Ascospiroketal A Through a AgI-Promoted Cyclization Cascade
- DOI:
10.1002/anie.201408905 - 发表时间:
2015-01-02 - 期刊:
- 影响因子:16.6
- 作者:
Chang, Stanley;Hur, Soo;Britton, Robert - 通讯作者:
Britton, Robert
The Kondrat'eva Reaction in Flow: Direct Access to Annulated Pyridines
- DOI:
10.1021/ol4013525 - 发表时间:
2013-07-19 - 期刊:
- 影响因子:5.2
- 作者:
Lehmann, Johannes;Alzieu, Thibaut;Britton, Robert - 通讯作者:
Britton, Robert
A Tandem Organocatalytic α-Chlorination-Aldol Reaction That Proceeds with Dynamic Kinetic Resolution: A Powerful Tool for Carbohydrate Synthesis
- DOI:
10.1021/ol401370b - 发表时间:
2013-07-19 - 期刊:
- 影响因子:5.2
- 作者:
Bergeron-Brlek, Milan;Teoh, Timothy;Britton, Robert - 通讯作者:
Britton, Robert
Human intestinal organoids from Cronkhite-Canada syndrome patients reveal link between serotonin and proliferation.
- DOI:
10.1172/jci166884 - 发表时间:
2023-11-01 - 期刊:
- 影响因子:15.9
- 作者:
Poplaski, Victoria;Bomidi, Carolyn;Kambal, Amal;Hoa, Nguyen-Phuc;Di Rienzi, Sara C.;Danhof, Heather A.;Zeng, Xi -Lei;Feagins, Linda A.;Deng, Nan;Vilar, Eduardo;McAllister, Florencia;Coarfa, Cristian;Min, Soyoun;Kim, Hyun Jung;Shukla, Richa;Britton, Robert;Estes, Mary K.;Blutt, Sarah E. - 通讯作者:
Blutt, Sarah E.
Contemporary synthetic strategies in organofluorine chemistry
有机氟化学的当代合成策略
- DOI:
10.1038/s43586-021-00042-1 - 发表时间:
2021-07-08 - 期刊:
- 影响因子:0
- 作者:
Britton, Robert;Gouverneur, Veronique;Hu, Jinbo - 通讯作者:
Hu, Jinbo
Britton, Robert的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Britton, Robert', 18)}}的其他基金
Discovery and Development of Enabling Tools for the Synthesis and Late-Stage Modification of Natural Products and Pharmaceuticals
天然产物和药物合成和后期修饰的支持工具的发现和开发
- 批准号:
RGPIN-2019-06468 - 财政年份:2022
- 资助金额:
$ 3.64万 - 项目类别:
Discovery Grants Program - Individual
Discovery and Development of Enabling Tools for the Synthesis and Late-Stage Modification of Natural Products and Pharmaceuticals
天然产物和药物合成和后期修饰的支持工具的发现和开发
- 批准号:
RGPIN-2019-06468 - 财政年份:2021
- 资助金额:
$ 3.64万 - 项目类别:
Discovery Grants Program - Individual
A Scalable Synthesis of the C14-C23 Fragment of Eribulin
艾日布林 C14-C23 片段的可扩展合成
- 批准号:
555427-2020 - 财政年份:2020
- 资助金额:
$ 3.64万 - 项目类别:
Alliance Grants
Discovery and Development of Enabling Tools for the Synthesis and Late-Stage Modification of Natural Products and Pharmaceuticals
天然产物和药物合成和后期修饰的支持工具的发现和开发
- 批准号:
RGPIN-2019-06468 - 财政年份:2020
- 资助金额:
$ 3.64万 - 项目类别:
Discovery Grants Program - Individual
Discovery and Development of Enabling Tools for the Synthesis and Late-Stage Modification of Natural Products and Pharmaceuticals
天然产物和药物合成和后期修饰的支持工具的发现和开发
- 批准号:
RGPIN-2019-06468 - 财政年份:2019
- 资助金额:
$ 3.64万 - 项目类别:
Discovery Grants Program - Individual
Direct 19F- and 18F- fluorination of heterocycles for medicinal chemistry and radiotracer synthesis
用于药物化学和放射性示踪剂合成的杂环直接 19F- 和 18F- 氟化
- 批准号:
520227-2017 - 财政年份:2018
- 资助金额:
$ 3.64万 - 项目类别:
Collaborative Research and Development Grants
Development of Enabling Methods for Natural Product and Medicinal Chemistry
天然产物和药物化学可行方法的开发
- 批准号:
RGPIN-2014-04644 - 财政年份:2018
- 资助金额:
$ 3.64万 - 项目类别:
Discovery Grants Program - Individual
Development of Enabling Methods for Natural Product and Medicinal Chemistry
天然产物和药物化学可行方法的开发
- 批准号:
RGPIN-2014-04644 - 财政年份:2017
- 资助金额:
$ 3.64万 - 项目类别:
Discovery Grants Program - Individual
Fluorinated amino acids as PET radiotracers for Central Nervous System (CNS) imaging and therapeutic applications
氟化氨基酸作为 PET 放射性示踪剂,用于中枢神经系统 (CNS) 成像和治疗应用
- 批准号:
520621-2017 - 财政年份:2017
- 资助金额:
$ 3.64万 - 项目类别:
Idea to Innovation
An Automated Synthesis Platform to Support Drug Discovery and Reaction Development
支持药物发现和反应开发的自动化合成平台
- 批准号:
RTI-2017-00201 - 财政年份:2016
- 资助金额:
$ 3.64万 - 项目类别:
Research Tools and Instruments
相似国自然基金
脊髓新鉴定SNAPR神经元相关环路介导SCS电刺激抑制恶性瘙痒
- 批准号:82371478
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
tau轻子衰变与新物理模型唯象研究
- 批准号:11005033
- 批准年份:2010
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
HIV gp41的NHR区新靶点的确证及高效干预
- 批准号:81072676
- 批准年份:2010
- 资助金额:33.0 万元
- 项目类别:面上项目
强子对撞机上新物理信号的多轻子末态研究
- 批准号:10675110
- 批准年份:2006
- 资助金额:36.0 万元
- 项目类别:面上项目
相似海外基金
Elucidation of the onset mechanism of dysphagia in basal ganglia disease and development of new treatment methods
阐明基底神经节疾病吞咽困难的发病机制并开发新的治疗方法
- 批准号:
23K09284 - 财政年份:2023
- 资助金额:
$ 3.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Bioorthogonal probe development for highly parallel in vivo imaging
用于高度并行体内成像的生物正交探针开发
- 批准号:
10596786 - 财政年份:2023
- 资助金额:
$ 3.64万 - 项目类别:
Development and evaluation of a combined X-ray transmission and diffraction imaging system for pathology
用于病理学的组合 X 射线透射和衍射成像系统的开发和评估
- 批准号:
10699271 - 财政年份:2023
- 资助金额:
$ 3.64万 - 项目类别:
Infant Immunologic and Neurologic Development following Maternal Infection in Pregnancy during Recent Epidemics
近期流行病期间妊娠期感染后婴儿的免疫和神经系统发育
- 批准号:
10784250 - 财政年份:2023
- 资助金额:
$ 3.64万 - 项目类别:
Development of an Oral Pan-Coronavirus Drug Cocktail
口服泛冠状病毒药物混合物的开发
- 批准号:
10714472 - 财政年份:2023
- 资助金额:
$ 3.64万 - 项目类别:
Development of multi-color 3D super-localization LiveFISH and LiveFISH PAINT to investigate the chromatin dynamics at any genomic scale
开发多色 3D 超定位 LiveFISH 和 LiveFISH PAINT,以研究任何基因组规模的染色质动态
- 批准号:
10725002 - 财政年份:2023
- 资助金额:
$ 3.64万 - 项目类别:
Development of multimode vacuum ionization for use in medical diagnostics
开发用于医疗诊断的多模式真空电离
- 批准号:
10697560 - 财政年份:2023
- 资助金额:
$ 3.64万 - 项目类别:
Catch and Release Radiolabeled Peptides: a new technology for radiotracer development
捕获并释放放射性标记肽:放射性示踪剂开发的新技术
- 批准号:
10593475 - 财政年份:2023
- 资助金额:
$ 3.64万 - 项目类别:
Monocyte-Derived Microglia in Development and after Neonatal Brain Injury
发育中和新生儿脑损伤后的单核细胞衍生的小胶质细胞
- 批准号:
10593385 - 财政年份:2023
- 资助金额:
$ 3.64万 - 项目类别:
Growth hormone regulating chondrocyte metabolism for osteoarthritis development
生长激素调节软骨细胞代谢促进骨关节炎的发展
- 批准号:
10730575 - 财政年份:2023
- 资助金额:
$ 3.64万 - 项目类别: